Your browser is no longer supported. Please, upgrade your browser.
Settings
ZOM Zomedica Pharmaceuticals Corp. daily Stock Chart
ZOM [AMEX]
Zomedica Pharmaceuticals Corp.
Index- P/E- EPS (ttm)-0.10 Insider Own0.20% Shs Outstand523.54M Perf Week-1.01%
Market Cap55.80M Forward P/E- EPS next Y-0.03 Insider Trans- Shs Float162.91M Perf Month-6.37%
Income-10.60M PEG- EPS next Q-0.01 Inst Own6.80% Short Float6.51% Perf Quarter-35.99%
Sales- P/S- EPS this Y-4.50% Inst Trans59.80% Short Ratio0.18 Perf Half Y-8.65%
Book/sh-0.08 P/B- EPS next Y25.00% ROA-166.90% Target Price- Perf Year-37.04%
Cash/sh0.00 P/C37.20 EPS next 5Y- ROE135.90% 52W Range0.11 - 0.50 Perf YTD-52.45%
Dividend- P/FCF- EPS past 5Y-28.50% ROI- 52W High-68.46% Beta-0.08
Dividend %- Quick Ratio1.20 Sales past 5Y- Gross Margin- 52W Low43.09% ATR0.01
Employees28 Current Ratio1.20 Sales Q/Q- Oper. Margin- RSI (14)44.45 Volatility3.06% 5.64%
OptionableNo Debt/Eq- EPS Q/Q82.10% Profit Margin- Rel Volume0.39 Prev Close0.16
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume59.88M Price0.16
Recom2.00 SMA20-2.81% SMA50-13.22% SMA200-33.01% Volume23,599,966 Change0.70%
Aug-10-20 04:15PM  
Aug-07-20 06:55AM  
Aug-03-20 06:55AM  
Jul-21-20 04:01PM  
04:01PM  
Jul-07-20 04:01PM  
Jul-01-20 10:30PM  
04:04PM  
Jun-30-20 09:00AM  
Jun-25-20 09:26AM  
Jun-16-20 06:05PM  
May-29-20 04:05PM  
May-26-20 10:16PM  
May-20-20 04:05PM  
May-11-20 06:55PM  
04:20PM  
Apr-21-20 06:55AM  
Apr-13-20 07:15PM  
Apr-07-20 11:32PM  
04:01PM  
Feb-26-20 05:25PM  
Feb-14-20 04:15PM  
Feb-12-20 08:43AM  
Feb-11-20 06:55AM  
Jan-30-20 06:55AM  
Jan-23-20 06:55AM  
Jan-20-20 06:55AM  
Dec-23-19 04:00PM  
Dec-03-19 06:55AM  
Nov-13-19 06:55AM  
Nov-12-19 04:53PM  
Nov-05-19 04:15PM  
Oct-31-19 06:55AM  
Oct-03-19 11:27AM  
Oct-01-19 09:17AM  
Sep-18-19 01:39PM  
Sep-17-19 06:55AM  
Sep-11-19 09:09AM  
09:00AM  
Sep-03-19 06:55AM  
Aug-19-19 06:55AM  
Aug-13-19 08:00AM  
Aug-08-19 04:08PM  
Aug-07-19 06:55AM  
Jul-25-19 06:55AM  
Jul-17-19 06:55AM  
Jun-26-19 10:05AM  
Jun-13-19 06:55AM  
Jun-12-19 04:35PM  
Jun-10-19 06:00AM  
May-21-19 06:55AM  
May-10-19 05:21PM  
06:00AM  
Mar-26-19 06:00AM  
Mar-25-19 04:01PM  
Mar-05-19 06:55AM  
Feb-26-19 04:05PM  
Jan-15-19 06:55AM  
Jan-14-19 06:55AM  
Dec-20-18 05:23PM  
Dec-19-18 06:00AM  
Nov-28-18 09:53AM  
Nov-27-18 06:51AM  
06:50AM  
Nov-26-18 07:25AM  
Nov-13-18 04:47PM  
Nov-12-18 04:30PM  
Oct-16-18 09:00AM  
Sep-18-18 06:55AM  
Aug-15-18 04:15PM  
Aug-09-18 04:01PM  
Jun-28-18 08:57PM  
Jun-25-18 05:59PM  
Jun-19-18 06:54AM  
Jun-14-18 06:15PM  
May-15-18 04:06PM  
04:01PM  
May-14-18 07:30AM  
May-10-18 06:55AM  
May-07-18 06:55AM  
Mar-26-18 09:00AM  
Mar-07-18 06:55AM  
Feb-28-18 04:11PM  
Feb-20-18 06:55AM  
Dec-01-17 09:00AM  
Zomedica Pharmaceuticals Corp., a development stage veterinary diagnostic and pharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. Its lead drug product candidate is ZM-007, an oral suspension formulation of metronidazole for the treatment of acute diarrhea in small dog breeds and puppies. The company is also developing ZM-012, a tablet formulation of metronidazole targeting the treatment of acute diarrhea in dogs; ZM-006, a transdermal gel formulation of methimazole targeting hyperthyroidism in cats; and ZM-011, a transdermal gel formulation of fluoxetine for the treatment of feline behavioral disorders, such as inappropriate urination. It has a collaboration agreement with Celsee Diagnostics, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and with Seraph Biosciences, Inc. for development and commercialization of novel pathogen detection system. The company was founded in 2015 and is headquartered in Ann Arbor, Michigan.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
POWERS JOHNNY DDirectorJul 07Buy0.16625,000100,000625,000Jul 07 04:53 PM